The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists

The presented expert paper discusses the high prevalence of hypercholesterolemia (HCH) in Russia. Insufficient use of lipid-lowering therapy in both primary and secondary prevention is indicated. Failure to achieve the target level of low-density lipoprotein cholesterol (HC) and low adherence (espec...

全面介紹

書目詳細資料

Principais autores:	Marina G. Bubnova, Albert S. Galyаvich, Marat V. Ezhov, David M. Aronov, Natalia N. Vinogradova, Gagik R. Galstyan, Viktor S Gurevich, Yuri A. Karpov, Natalia A. Koziolova, Elena D. Kosmacheva, Gennady V. Matyushin, Igor V. Sergienko, Alexander E. Philippov, Iurii Sh. Khalimov
格式:	Artigo
語言:	Inglês
出版:	Concilium Medicum 2025-01-01
叢編:	КардиоСоматика
主題:	atherosclerosis cardiovascular diseases prevention lipid-lowering therapy statins pitavastatin
在線閱讀:	https://cardiosomatics.ru/2221-7185/article/viewFile/676903/198223
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!